We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Draft EMA Guideline Sets Biosimilar Groundwork, Clinical Study Comparisons
Draft EMA Guideline Sets Biosimilar Groundwork, Clinical Study Comparisons
May 8, 2013
The European Medicines Agency (EMA) on May 2 published draft guidelines aimed at facilitating global development of biosimilars and avoiding unnecessary repeats of clinical trials.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor